MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
N/A
Issued Date -
Dec 21, 2023
app pub date -
Apr 28, 2023
filing date -
Mar 18, 2008
priority date (Note) -
Published
status (Latency Note)
![]() |
A preliminary load of PAIR data current through [] has been loaded. Any more recent PAIR data will be loaded within twenty-four hours. |
PAIR data current through []
A preliminary load of cached data will be loaded soon.
Any more recent PAIR data will be loaded within twenty-four hours.
![]() |
Next PAIR Update Scheduled on [ ] |

Importance
Loading Importance Indicators...

Calculated Rating
US Family Size
|
Non-US Coverage
|
Abstract
The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
First Claim
all claims..Other Claims data not available
Family
Loading Family data...

- 15 United States
- 10 France
- 8 Japan
- 7 China
- 5 Korea
- 2 Other
Patent Owner(s)
Patent Owner | Address | |
---|---|---|
ARENA PHARMACEUTICALS INC | 6154 NANCY RIDGE DRIVE SAN DIEGO CA 92121 |
International Classification(s)

- 2023 Application Filing Year
- A61K Class
- 11803 Applications Filed
- 2060 Patents Issued To-Date
- 17.46 % Issued To-Date
Inventor(s)
Inventor Name | Address | # of filed Patents | Total Citations |
---|---|---|---|
CHEN, Weichao | San Diego, US | 20 | 82 |
# of filed Patents : 20 Total Citations : 82 | |||
KRAMER, Bryan A | San Diego, US | 13 | 94 |
# of filed Patents : 13 Total Citations : 94 | |||
SADEQUE, Abu JM | San Diego, US | 13 | 65 |
# of filed Patents : 13 Total Citations : 65 | |||
SHIFRINA, Anna | San Diego, US | 18 | 102 |
# of filed Patents : 18 Total Citations : 102 | |||
SHIN, Young-Jun | San Diego, US | 44 | 569 |
# of filed Patents : 44 Total Citations : 569 | |||
TRAN, Thuy-Anh | San Diego, US | 49 | 354 |
# of filed Patents : 49 Total Citations : 354 | |||
VALLAR, Pureza | Chula Vista, US | 9 | 72 |
# of filed Patents : 9 Total Citations : 72 | |||
ZOU, Ning | San Diego, US | 38 | 245 |
# of filed Patents : 38 Total Citations : 245 |
Cited Art Landscape
- No Cited Art to Display
Loading Cited Art Landscape... 

Patent Citation Ranking
- 1 Citation Count
- A61K Class
- 90.63 % this patent is cited more than
- 2 Age
Forward Cite Landscape
- No Forward Cites to Display
Loading Forward Cite Landscape... 

Maintenance Fees
Fee | Large entity fee | small entity fee | micro entity fee | due date |
---|---|---|---|---|
3.5 Year Payment | $1600.00 | $800.00 | $400.00 | Jun 21, 2027 |
7.5 Year Payment | $3600.00 | $1800.00 | $900.00 | Jun 21, 2031 |
11.5 Year Payment | $7400.00 | $3700.00 | $1850.00 | Jun 21, 2035 |
Fee | Large entity fee | small entity fee | micro entity fee |
---|---|---|---|
Surcharge - 3.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 7.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge - 11.5 year - Late payment within 6 months | $160.00 | $80.00 | $40.00 |
Surcharge after expiration - Late payment is unavoidable | $700.00 | $350.00 | $175.00 |
Surcharge after expiration - Late payment is unintentional | $1,640.00 | $820.00 | $410.00 |
Full Text
US Patent Application No: 2023/0404,954
MODULATORS OF THE PROSTACYCLIN (PGI2) RECEPTOR USEFUL FOR THE TREATMENT OF DISORDERS RELATED THERETO
Abstract
The present invention relates to amide derivatives of Formula (XIIIa) and pharmaceutical compositions thereof that modulate the activity of the PGI2 receptor.
Description
Claims
Claims data not available

Legal Events

Matter Detail

Country:
Application No:
Patent No:
Application Publication No:
Status:
Priority Date:
Filing Date:
Matter Type:
Local Registration No:
Docket No:
Secondary System Identifier (SSI):
Customer Application No:
Filing Type:
Request for Examination Date:
Parent Filing Date:
Complete Specification Date:
PCT Filing Date:
National Entry Date:
First Publication Date:
Allowance Date:
Grant Date:
Grant Publication Date:
Claims:
Independent Claims:
Law Firm:
Renewals Detail

Applicant:
Applicant ID:
Entity Size:
Renewal Status:
Renewal Base Date:
Renewal Trigger Date: